Table 1.
Model System | Treatment | Anti-Oxidative Effects | Anti-Inflammatory Effects | Anti-Apoptotic Effects | Reference |
---|---|---|---|---|---|
Quercetin | |||||
PC12 cells | H2O2 | ↓ ROS production, ↓ MDA levels, ↑ GSH content, ↑ catalase, SOD and GSH-Px expression | ↓ Bax and ↑ Bcl-2 expression, ↓ cleaved caspase-3 and -9, ↓ p53 expression, ↑ activation of PI3K/Akt | [203,204,206] | |
PC12 cells | Aβ25-35 | ↓ levels of MDA, and HO-1 protein, ↑ levels of SOD, GSH-Px, catalase, Sirt1 and Nrf2 protein | [212] | ||
P19 neurons | H2O2 | ↓ ROS production | ↓ caspase-3/7 activation, ↓ nuclear condensation, ↓ p53 and ↑ Bcl-2 expression, ↑ activation of PI3K/Akt and ERK1/2 | [186,188] | |
Cerebellar granule neurons | H2O2 | ↑ GSH levels, Nrf2 translocation, ↑ expression of GCLC mRNA | [205] | ||
P19 neurons | CuSO4 | ↓ ROS production in moderate OS, pro-oxidative activity in severe OS | ↓ caspase-3/7 activation, ↓ chromatin condensation, ↓ PUMA expression, ↑ activation of PI3K/Akt and ERK1/2 | [123] | |
HT22 cells | Okadaic acid | ↓ levels of ROS and MDA, ↑ levels of SOD and GSH-Px, ↑ mitochondrial membrane potential | ↓ expression of NF-κB p-p65 | ↓ Bax levels, ↓ cleaved caspase-3, activation of PI3K/Akt pathway, inhibition of p38 and JNK, reduced intracellular Ca2+ levels | [213,215] |
Drosophila AD model | Restored expression of genes involved in p53 signaling | [219] | |||
Wild-type C57BL/6N mice | LPS | ↓ gliosis, ↓ expression of p-NF-κB, ↓ levels of TNF-α, IL-1β, COX-2 and iNOS | ↓ cytochrome c release and Bax/Bcl-2 ratio, ↓ caspase-3 activity, ↓ synaptic loss | [200] | |
Wistar albino rats (hippocampus) | Al-lactate | ↓ ROS production, ↑ MnSOD activity, preserved mitochondrial morphology | ↓ Bax and ↑ Bcl-2 expression, ↓ cytochrome c expression, ↓ caspase-3 activation, ↓ DNA fragmentation, ↓ p53 expression | [207] | |
APPswe/ PS1dE9 mice (C57/BL) (cortex, hippocampus) |
Restoration of mitochondrial membrane potential, ROS levels and ATP production | [209] | |||
3xTg-AD mice (hippocampus) | ↓ activation of microglia, ↓ iNOS and COX-2 immunoreactivity, ↓ IL-1β | [210] | |||
Sprague Dawley rats (brain homogenate) | Aβ | ↑ SOD, catalase and GSH, ↓ MDA, activation of Nrf2/HO-1 pathway | [220] | ||
MN9D dopaminergic cells | ↑ mitochondrial biogenesis and mtDNA content | ↑ pAkt expression, ↑ BDNF levels | [225] | ||
SK-N-MC neuroblastoma cells | Mn | ↑ SOD and catalase activity, ↑ GSH levels, ↓ MDA, ↑ levels of Nrf2 and HO-1 | ↓ level of P-IκBα and NF-κB p65 | ↓ staining with Hoechst 33342, ↓ number of apoptotic cells | [226] |
Albino rats | rotenone | ↓ MDA levels, ↑ thioredoxin reductase reactivity | ↓ DNA fragmentation | [222] | |
Sprague Dawley rats (brain homogenate) | Mn | ↓ ROS and protein carbonyl levels, ↑ Cu/Zn-SOD activity, ↑ Nrf2 and HO-1 mRNAs | ↓ TNF-α, IL-1β, IL-6, COX-2 and iNOS protein expression, ↓ NF-κB and iNOS mRNAs | ↓ Bax expression, ↓ cytochrome c expression, ↓ cleaved caspase-3 expression, ↓ PARP-1 levels | [226] |
3-NP-induced model of HD in Wistar rats (striatum) | Restored ATP levels, ↑ mitochondrial SOD and catalase activity, ↓ MDA levels and ↑ thiol content | ↓ number of pyknotic and condensed nuclei | [227] | ||
Rutin | |||||
Sprague Dawley rats (hippocampus) | TMT | ↓ mRNA markers of reactive microglia and pro-inflammatory cytokines | [234] | ||
Wistar rats (hippocampus) | STZ | ↓ TBARS content and nitrite levels, ↑ GSH, ↑ GPx, GR and catalase activity | ↓ GFAP, COX-2, iNOS, IL-8 and p65 NF-κB expression | Restored PARP-1 activity, prevented histological abnormalities | [235] |
PP/PS1 (APPswe/ PSEN1dE9) mice (brain homogenate) |
↓ microglial activation, ↓ TNF-α, IL-1β, IL-6, ↑ IL-4 and IL-10 | Reversed synaptic dysfunction, enhanced microglial Aβ phagocytosis | [236] | ||
Sprague Dawley rats (brain homogenate) | Colistin | ↑ SOD, GSH-Px and catalase content, ↑ GSH levels, ↓ MDA, ↑ levels of Nrf2 | ↓ GFAP expression, ↓ expression of NF-κB, TNF-α, ↓ nNOS activity | ↑ Bcl-2 and ↓ Bax expression, ↓ caspase-3 activity, ↓ p53 level, modulation of ERK1/2 pathway | [238] |
Myricetin | |||||
Primary neuronal cultures | Glutamate | ↓ ROS production | ↓ calcium overload, ↓ activation of caspase-3, ↓ nuclear fragmentation | [241] | |
Primary neuronal cultures | Aβ | ↓ nuclear fragmentation, ↓ caspase-3 activation | [242] | ||
MES23.5 cells | MPP+ | ↓ ROS production, restored mitochondrial membrane potential | ↓ nuclear condensation, ↓ Bax/Bcl-2 ratio, ↓ caspase-3 activation, ↓ pJNK expression | [245] | |
Myricitrin | |||||
C57BL/6 mice (substantia nigra) | 6-OHDA | ↓ number of Iba1-positive cells, ↓ expression TNF-α | [261] | ||
Sprague Dawley rats (brain homogenate) | TBI of the spinal cord | ↑ SOD, GSH-Px and catalase content, ↓ MDA levels | ↓ TNF-α, IL-1β, IL-6 and NF-κB p65 subunit content, ↓ COX-2 and TGF-β1 mRNA expression | ↓ Bax/Bcl-2 ratio, ↓ p53 levels | [262] |
Fisetin | |||||
HT22 cells | Glutamate | ↓ ROS production, ↑ GSH levels | [265] | ||
APPswe/ PS1dE9 mice (hippocampus) |
↓ protein carbonylation | ↓ cPLA2 levels, ↓ COX-2, ↓ astrocytic reactivity | ↑ pERK, preserved expression of synaptic markers | [268] | |
C57BL/6N mice (hippocampus) | Aβ | ↓ expression of p-IKKβ, p-NF-ҡB, TNFα and IL-1β, ↓ number of activated Iba-1- and GFAP-positive cells | ↓ Bax expression, ↑ Bcl-2 expression, ↓ cytochrome c activation, ↓ cleaved caspase-3 and -9, ↓ expression of p53 and PARP-1, ↑ activation of PI3K/Akt, restored synaptic function | [271] | |
C57BL/6N mice (hippocampus) | LPS | ↓ ROS production and lipid peroxidation, ↑ GSH levels | ↓ reactivity of TLR4 and pNF-ҡB, ↓ TNFα, IL-1β and COX-2, ↓ activation of Iba-1- and GFAP-positive cells | ↓ expression of cytochrome c, Apaf-1, caspase-3 and -9 and PARP-1, ↓ activation of JNK pathway, prevented morphological changes | [272] |
Swiss albino mice (cortex and hippocampus) | AlCl3 | ↓ Bax and ↑ Bcl-2 mRNA expression, ↓ expression of cytochrome c, caspase-3 and -9, ↓ expression of p53, ↓ number of TUNEL-positive neurons, ↓ JNK activation | [273] | ||
C57BL/6N mice (striatum) | MPTP | ↓ number of TUNEL-positive neurons | [274] | ||
Wistar rats (brain homogenate) | D-galactose | ↓ production of ROS and NO, ↓ protein carbonylation and lipid hydroperoxidation, ↑ SOD and catalase levels, ↑ total thiol content | ↓ expression of TNF-α and IL-1β | [277] | |
C57BL/6N mice | D-galactose | ↓ ROS and MDA levels, ↑ levels of Sirt1, Nrf2 and HO-1 | ↓ pNF-ҡB, NF-ҡB, Iba-1, GFAP, IL-1β, TNF-α and iNOS | ↓ Bax and ↑ Bcl-2 expression, ↓ expression of caspase-3 and PARP-1 | [278] |
Kaempferol | |||||
PC12 | HNE | ↑ Bcl-2 levels, ↓ caspase-3 activation, ↓ nuclear condensation and PARP-1 cleavage, inhibited activation of NADPH oxidase and JNK phosphorylation | [283] | ||
SH-SY5Y cells | Rotenone | ↓ production of ROS, ↓ mitochondrial carbonyls, restored mitochondrial function | Prevented round-shape phenotype, preserved nuclear morphology, ↓ reduced caspase-9/3 cleavage, ↓ activation of JNK and p38 | [168] | |
SH-SY5Y cells | Rotenone | ↓ production of ROS, ↓ MDA content, ↑ GSH, SOD, GSH-Px and catalase levels | ↑ expression of TH | [282] | |
Albino rats | Rotenone | ↓ production of ROS, ↓ MDA levels, ↑ GSH, SOD, GSH-Px and catalase levels | ↓ levels of TNF-α and IL-6 | [282] | |
Drosophila model of PD | ↑ free radical scavenging, ↓ TBARS and protein carbonyl content, ↑ SOD, GSH-S-transferase and catalase activity | ↓ reduced caspase-3 and -9 activity, ↑ TH staining and L-DOPA levels | [283] | ||
Drosophila model of AD | ↑ GSH content, ↓ TBARS and protein carbonyl content | ↓ caspase-3 and -9 activity | [286] | ||
C57BL/6 mice (substantia nigra) | MPTP | ↑ SOD and GSH-Px activity, ↓ MDA content | ↑ TH staining | [285] | |
Kunming mice (hippocampus) | D-galactose | ↓ TBARS, ↑ SOD | ↑ activation of ERK/CREB pathway | [287] | |
Morin | |||||
SH-SY5Y cells | Aβ | ↓ production of ROS | ↓ staining with Hoechst 33342 and PI | [293] | |
Differentiated PC12 cells | MPP+ | ↓ production of ROS | ↓ caspase-3 activity | [290] | |
Primary cultured neurons | MPP+ | ↓ ROS production, prevented mitochondrial membrane disruption | ↓ staining with Hoechst 33342 and PI | [294] | |
Primary cultured astrocytes | MPP+ | ↓ astrocyte activation, ↓ nuclear translocation of p65 NF-ҡB | [294] | ||
Cultured cortical neurons | Aβ | ↓ ROS production and protein oxidation, ↑ SOD and catalase activity, ↓ calcium uptake and mitochondrial membrane depolarization, restored respiratory capacity | ↓ PI staining, ↓ cytochrome c release | [291] | |
Sprague Dawley rats (brain homogenate) | Ifosfamide | ↓ MDA levels, ↑ GSH, SOD, GSH-Px and catalase activities, ↑ Nrf2 levels | ↓ GFAP levels, ↓ NF-ҡB and TNF-α, ↓ nNOS activity | ↓ caspase-3 and p53 levels, ↓ JNK activation | [295] |
APPswe/ PS1dE9 mice (cortex, hippocampus) |
↓ activation of glial cells | ↓ cerebral Aβ production, ↑ expression of synaptic markers | [291] | ||
C57BL/6 mice (striatum and substantia nigra) | MPTP | ↓ astrocyte activation, ↓ levels of TNF-α | ↓ loss of dopaminergic cells | [294] | |
B57/BL mice (substantia nigra) | MPTP | ↑ number of TH-positive cells | [290] | ||
Isorhamnetin | |||||
PC12 cells | H2O2 | ↓ formation of ROS, ↑ catalase activity | ↓ calcium levels, ↓ caspase-3 activation, ↑ Akt signaling and ↓ activation of JNK pathway | [301] | |
N2a cells | TG | ↓ formation of ROS | ↓ calcium overload, ↓ PI fluorescence, ↑ phosphorylation of PKCε | [302] | |
HT22 neurons | OGD/R | ↑ Akt/Sirt1/Nrf2/HO-1 pathway | [303] | ||
Albino rats (hippocampus) | Aβ25-35 | ↓ formation of H2O2, ↓ MAO activity | ↓ expression of iNOS and IL-1β mRNA | [308] | |
Albino mice (prefrontal cortex and hippocampus) | SCP | ↓ MDA and nitrite production, ↑ GSH levels, ↑ SOD and catalase activities | [309] |
Aβ—amyloid β; cPLA2—cytosolic phospholipase A2; GSH—glutathione; GCLC—glutamate–cysteine ligase catalytic subunit; GFAP—glial fibrillary acidic protein; GSH-Px—glutathione peroxidase; MAO—monoamino oxidase; MDA—malondialdehyde; MPP+—1-methyl-4-phenylpyridinium; MPTP—1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-NP—3-nitropropionic acid; OGD/R– oxygen–glucose deprivation and reoxygenation; 6-OHDA—6-hydroxydopamine; PI—propidium iodide; PUMA—p53-upregulated mediator of apoptosis; ROS—reactive oxygen species; SCP—scopolamine (muscarinic antagonist); SOD—superoxide dismutase; STZ—streptozotocin; TG—thapsigargin (inductor of endoplasmic reticulum stress); TBARS—thiobarbituric acid reactive substances; TH—tyrosine hydroxylase; TLR4—Toll-like receptor 4; TMT—trimethyltin.